Use of rasagiline

PDMED_RASAGILINE

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N04BD02

551

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

453

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

453

diagram downward connector

Include endpoints None

453

diagram downward connector
PDMED_RASAGILINE

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
?
Number of individuals
442 210 232
?
Unadjusted prevalence (%)
0.14 0.12 0.17
?
Mean age at first event (years)
64.73 63.82 65.55

?
Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.10 8.35 [4.71, 14.81] 3.7e-13 50
15 years 0.02 3.68 [1.96, 6.88] 4.7e-5 22
5 years 0.01 7.19 [4.04, 12.80] 2.0e-11 25
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: PDMED_RASAGILINE – Use of rasagiline
GWS hits:

Survival analyses between endpoints

Plot

before Use of rasagiline
after Use of rasagiline

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Use of rasagiline